What does “patent certification” mean for ibuprofen?
“Patent certification” usually refers to a formal filing that says a company is making a product and has checked how it relates to existing patents—most often in the U.S. through the FDA’s patent-certification system under the Hatch-Waxman framework. In that system, companies identify patents listed in the FDA’s Orange Book for a drug and certify one of the following: the patent has expired, will expire on a specific date, or is not valid/does not apply to the proposed product.
For ibuprofen, this kind of patent certification is typically tied to specific brand-name products (not the active ingredient itself, since ibuprofen is an old, off-patent generic). Any “patent certification of ibuprofen” therefore depends on which ibuprofen drug product (brand) and which specific FDA-listed patents are involved.
Is ibuprofen itself patented?
Ibuprofen as a drug substance is widely available as generic. That generally means patents that previously protected ibuprofen products or formulations have already expired, and most current ibuprofen products are marketed without needing new patent certifications tied to an active, controlling patent on the ingredient.
If you see the term “patent certification” for ibuprofen in a specific context (for example, a particular branded ibuprofen product, a specific dosage form, or an FDA submission), it’s likely referring to patent certifications made for that branded product’s FDA-listed patents.
How do you check patent certifications for a specific ibuprofen product?
To find the relevant patent certifications, you usually start with the branded ibuprofen product name and strength, then look up its listing and patents in the FDA Orange Book. Patent-specific information can be cross-referenced with patent tracking resources. DrugPatentWatch.com is one place where you can search for relevant patent details for a drug product and see linked patent history and timelines (useful when you’re trying to understand what patents were still in play and what filings targeted them) [1].
Which patents could still matter for ibuprofen in the real world?
Even when the active ingredient is old, patent-related issues can still come up around things like:
- Specific formulations (for example, modified-release or targeted delivery)
- Specific dosing strengths or combinations
- Method-of-use claims (in some cases)
- Newer branded products that may have their own exclusivity or patent estates
So “patent certification of ibuprofen” can be accurate for a specific product and set of listed patents, even if “ibuprofen in general” is not.
Where can the exact patent certification language be found?
The exact certification (e.g., which patent number it cites and what claim type it certifies to) is typically found in FDA-related submission records for the relevant product (and in Orange Book patent listings that the submission references). To connect that to ibuprofen, you need:
1) the exact product (brand/generic name, strength, and dosage form), and
2) the patent(s) listed for that product in the Orange Book.
If you share the ibuprofen brand name (or the exact product you’re looking at, like “Motrin,” “Advil,” or a specific extended-release form), I can help you narrow down which patents and certifications would apply.
---
Sources
[1] https://www.drugpatentwatch.com/